QB3, A University of California Initiative, Shares Gap Funding Program Successes
The “valley of death”—the lack of proof-of-concept funding for scientists who want to commercialize their research—continues to frustrate entrepreneurs at the University of California. There has always been a gap between the discovery phase, which the NIH will fund, and proven technology that can attract private investment. That gap has widened over the past few years because […]
Beat Biotherapeutics, A U Washington Start-up, Raises $2.5M For Heart Failure Treatment
Beat Biotherapeutics looked like it was in trouble after its co-founder and CEO died suddenly in June 2009. But the University of Washington spinout is definitely back in business, after recruiting a veteran CEO and raising another $2.5 million to advance an experimental treatment for heart failure.
Rutgers University, UMDNJ Start-up, NovoPedics, Secures $500K For Implantable Device
Newly formed NovoPedics, Inc., has received a commitment of up to $500,000 from Foundation Venture Capital Group (FVCG) to advance its development of an implantable meniscus replacement/regeneration medical device.
University of Dayton Alumni Fund Offers $175K To Viable Business Ideas
Now in its seventh year, the competition offers nearly $175,000 in total support with a $25,000 top prize along with expert advice on transforming a great idea into a viable, marketable, innovative business plan. The competition was recognized last year as one of the 15 largest college business plan competitions by Under30CEO, a news and […]
Wayne State University Warrior Fund Supports Four Student Start-ups
Late last month, student-run startups from the Blackstone LaunchPad incubator gathered for pitch competition on the campus of Wayne State University (WSU). The startups were able to pitch for up to $5,000 in funding from the Warrior Fund, WSU’s pre-seed fund to support student tech startups. Blackstone, which operates on the campuses of WSU and Walsh College in […]
St.Louis University’s First Spinout, Antegrin Therapeutics, Gets Investment From BioGenerator
BioGenerator, the local nonprofit venture development group, announced Tuesday it will invest in Antegrin Therapeutics, a startup company that develops compounds to treat lung disease. Antegrin was founded based on science developed by researchers at St. Louis University and the Center for World Health & Medicine, the university’s center dedicated to the treatment of often […]
University of Kansas POC fund awards $250K
Lawrence, KS, March 26, 2013 –(PR.com)– The University of Kansas continues to move innovations from the laboratory to the marketplace. As part of this effort, five KU researchers have been awarded $50,000 each through the university’s new Proof of Concept Fund for projects that are near the commercialization stage.
Virginia Innovation Partnerships puts $861K in 18 university research projects
A statewide network designed to accelerate innovation and economic growth has awarded $861,086 to 18 university research projects across the commonwealth. The Virginia Innovation Partnership, created last fall as part of the U.S. Department of Commerce’s i6 Challenge, provides proof-of-concept funding to advance early-stage research, also connecting academic researchers with mentors, corporations and investors to accelerate commercialization of the […]
Clearside Biomedical, GA Tech venture spin-out, lands $7.9M investment
Clearside Biomedical, Inc. an Atlanta-based ophthalmic pharmaceutical company launched from research at Emory University and the Georgia Institute of Technology, has received $7.9 million in funding to continue drug and technology development for treatment of ocular diseases. The new funding is in addition to a $4 million venture capital investment received by Clearside Biomedical in […]
UCSD student fund invests $25K in Savara Pharmaceuticals, a Texas start-up
After launching its student-run Rady Venture Fund three years ago, UCSD’s Rady School of Management says today it has invested $25,000 in its biggest deal so far—a $16 million Series B investment in Savara Pharmaceuticals of Austin, TX. Savara, founded in 2007, is in mid-stage development of an inhaled antibiotic to treat methicillin-resistant Staphylococcus aureus (MRSA) infections in […]